BHCM
PLSE icon

Brevan Howard Capital Management’s Pulse Biosciences PLSE Stock Holding History

Brevan Howard Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,164
Closed -$263K – 2472
2026
Q1 		$263K Buy
+12,164
New +$225K ﹤0.01% 1715
2025
Q3 		– Sell
-14,265
Closed -$215K – 2205
2025
Q2 		$215K Buy
+14,265
New +$237K ﹤0.01% 1686

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Brevan Howard Capital Management's PLSE Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 12,164 shares — an estimated $263K sold.

Brevan Howard Capital Management first reported a position in PLSE in Q2 2025 and held it in 2 quarters. The position peaked at $263K in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 12,164 Pulse Biosciences shares in Q2 2026, an estimated $263K.
  • Brevan Howard Capital Management first reported a position in Pulse Biosciences in Q2 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Pulse Biosciences position peaked at $263K in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.